Title: Methamphetamine Use Among Adolescents
1Methamphetamine Use Among Adolescents
- Rachel Gonzales, Ph.D.
- UCLA Integrated Substance Abuse Programs
- Semel Institute for Neuroscience and Human
Behavior - David Geffen School of Medicine at UCLA
- www.methamphetamine.org
2Presentation Objectives
- Examine scope of MA use among adolescents around
the country, with focus on the U.S. - Highlight unique trends
- Review research on treatment outcome studies
specific to MA-abusing adolescents
3Global Snapshot
- European National Survey prevalence of MA use
among adolescents has been on the rise since
1990. - Czech Republic Survey 10 of youth had used MA
(Pervitin) in their lifetime. - Taiwan northern Thailand data MA use is highly
problematic among adolescents. - Australian Survey MA use among adolescents is
not uncommon - prevalence is 7. - Canadian Survey lifetime MA use (prevalence) is
high among Canadian adolescents (11.2). - Cape Town, South Africa Survey 42 of adolescent
treatment admissions were for MA dependence.
4National Picture Current Use
Past Month Drug Use
Source NIDA, MTF, 2007.
5National Measurement Challenges
- While beneficial, national surveys tend to
underrepresent adolescent illicit drug use - Dropouts and delinquent youth
- Homeless and runaways
- Foster care youth
- Other Sources
- Juvenile Justice Data High rates of MA use among
juvenile arrestees in Western US (Pennell et al.,
2000) Recent study found MA more common among
females in juvenile detention (30) in
California (McDonnell et al, 2008). - Emergency Room Data MA is commonly detected in
most adolescent cases (especially in CA) - Treatment Admission Data
6Treatment Admissions in California
SOURCE California Alcohol and Drug Data System
2001-06
7Adolescent Treatment Admissions in Los Angeles
17 years and under
18-25 years old
Source LA County, 2004-05
8Treatment Outcome Studies
- Very few published on MA and youth in the U.S.
- Research literature is growing with a heavy
emphasis on MA and Taiwanese/ Japanese youth.
9Treatment Study 305 Adolescents 13-18
90 dependent on MA
N90
N215
Source Rawson et al., 2005
10- Treatment Study found
- Older teens (ages 17-18) more likely to use than
younger adolescents. - Greater psychological legal dysfunction than
non-MA users. - More alcohol drug use during treatment than
non-MA users. - Greater drop out rates than non-MA users.
- No injectors (14 smoke, 12 smoke/snort, 4
snort)
Source Rawson et al., 2005
11LA County Treatment Study (N4,430)
- Examined data from outpatient and residential
treatment from 2000-05. - Compared treatment response of Marijuana users to
MA users aged 12-24.
Source Gonzales et al., 2008
12LA County Youth Treatment Admissions for MA and MJ
Source Gonzales et al., 2008
13- LA County Study found
- Compared to MJ users MA users more likely to be
- Female
- On probation/parole
- Older aged (gt17)
- Have previous treatment episodes
- Enrolled in residential settings
- Adherent to treatment poorer retention
Source Gonzales et al., 2008
14Ethnic Differences among MA using Females in
Treatment
15LA County Treatment Patterns
- 89 of MJ users in outpatient treatment
- 46 of MA users in residential treatment
Source Gonzales et al., 2008
16Research on Risk Factors
- A 3-year CASA study on adolescents (8-22) found
that clinically, MA users are symptomatic of low
self-esteem, mood anxiety disorders, and past
victims of physical/sexual abuse - MA using females became dependent faster and
suffered adverse affects sooner than males - Research from Taiwan indicate that MA using males
exhibit more deviant behavioral problems ASPD,
ADHD and females have more emotional/mood
problems (Yen Chung, 2006) - Study on 18-24 year olds found that MA use
heightens risk for engaging risky behaviors
violence, multiple sex partners, unprotected
sex (Baskin-Sommers Sommers, 2006)
Source National Center on Addiction and
Substance Abuse at Columbia University, 2003
17Risk Factors for Relapse among MA Using
Adolescents
- Psychiatric Disorder Status
- Lack of emotional stability
- Low educational level
- Social pressure Social in-adaptation
Yen Chang, 2005 (Taiwanese sample, N60)
18Summary
- Need to consider all critical data sources to
understand the scope of MA use among adolescents. - Need to pay attention to gender and ethnic
differences and other risk factors for MA use
relapse among adolescents to tailor treatment
appropriately.
19Acknowledgements
- Richard Rawson, Ph.D., UCLA ISAP
- Michael McCann, M.A., Matrix Institute
- Jeanne Obert, M.A., Matrix Institute
20Contact Information
- Rachel Gonzales, Ph.D.
- rachelmg_at_ucla.edu
- www.uclaisap.org
- www.methamphetamine.org